compared to its average ratio and a 36-month beta value of 2.79. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.” The average price point forecasted by analysts for Praxis P
Related Keywords
Copenhagen , Køavn , Denmark , Boston , Massachusetts , United States , Souza Marcio , Nasdaq , Movement Disorder Society , Praxis Precision Medicines Inc , Movement Disorders , International Congress , International Parkinson , Praxis Precision Medicines , Precision Medicines Inc , Day Moving , Nasdaq Prax , Ydrax , Rax Stock , Raxis Precision Medicines Inc , ,
comparemela.com © 2020. All Rights Reserved.